Diabetische Retinopathie und Makulopathie

Schlüsselwörter

diabetische Retinopathie - Makulopathie - Früherkennung

Key words

diabetic retinopathy - maculopathy - screening

Literatur

• 1 Degenring R F, Kreissig I, Jonas B J. Intraokulare Triamcinolongabe bei diffusem diabetischen Makulaödem.  Ophthalmologe. 2004;  101 251-254
• 2 Diabetic Retinopathy Vitrectomy Study Research Group . Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5.  Arch Ophthalmol. 1990;  108 958-964
• 3 Dillinger P, Mester U. Vitrectomy with removal of the internal limiting membane in chronic diabetic macular oedema.  Graefes Arch Clin Exp Ophthalmol. 2004;  242 630-637
• 4 Early Treatment Diabetic Retinopathy Study (ETDRS) Group . Results and summary.  Ophthalmology. 1991;  (Suppl 5) 98 739-840
• 5 Frank R N. Diabetic retinopathy.  N Engl J Med. 2004;  350 48-58
• 6 Gaede P, Vedel P, Larsen N, Jensen G V, Parving H H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.  N Engl J Med. 2003;  348 383-393
• 7 Hörle S, Gruner F, Kroll P. Epidemiologie diabetischer Erblindungen- eine Übersicht.  Klin Monatsbl Augenheilkd. 2002;  219 777-784
• 8 Jonas B J, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.  Am J Ophhthalmol. 2001;  132 425-427
• 9 Klein R, Klein B E, Moss S E, Cruickshanks K J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema.  Ophthalmology. 2000;  102 7-16
• 10 Lang G E. Medikamentöse Therapie der diabetischen Retinopathie.  Ophthalmologe. 2004;  101 1165-1170
• 11 Lenfant C. Shattuck lecture: clinical research to clinical practice - lost in translation?.  N Engl J Med. 2003;  349 868-874
• 12 Malone J I, Morrison A D, Pavan P R, Cuthbertson D D. Diabetic Control and Complications Trial. Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years’ duration screened for the diabetes control and complications trial.  Diabetes Care. 2001;  24 522-526
• 13 Microvascular and acute complications in IDDM patients: the EURODIAB Complications Study.  Diabetologia. 1994;  37 278-285
• 14 UKPDS Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.  Lancet. 1998;  352 837-853
• 15 van Hecke M V, Dekker J M, Stehouwer C D, Polak B C, Fuller J H, Sjolie A K, Kofinis A, Rottiers R, Porta M, Chaturvedi N. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study.  Diabetes Care. 2005;  28 1383-1389
• 16 von Stackelberg J -M. AOK im Dialog, DMP - Höhere Versorgungsqualität für chronisch Kranke. Frankfurt, KomPart Verlagsgesellschaft mbH & Co KG 2005: 31-37